Point-of-care diagnostics platform transitioning from prototype to production
Vital Bio builds hardware and software for point-of-care lab testing, with a stack spanning embedded systems (ARM Cortex-M, Rust, Yocto), cloud infrastructure (AWS), and traditional DevOps tooling (GitLab CI/CD, Jenkins, Docker). The project list and hiring mix reveal a company in mid-stage scaling: engineering and manufacturing roles dominate, with active work on assay integration, production-scale process transition, and automated failure detection—typical challenges when moving diagnostic devices from prototype validation into volume manufacturing.
Vital Bio develops an integrated ecosystem of diagnostic devices, software, and services for point-of-care testing, launched in 2019 and based in Oakville, Ontario. The company targets preventative healthcare through radically simplified lab testing, with core capabilities in chemistry, hematology, and immunoassay. At 51–200 employees and hiring primarily in Canada, Vital is scaling manufacturing and engineering capacity while managing the technical and operational complexity of transitioning assay platforms from prototype builds to production systems. Key operational focus areas include supplier management, instrumentation reliability, and security hardening of the diagnostic platform.
Embedded systems (ARM Cortex-M, Rust, Yocto, Buildroot), AWS for cloud infrastructure, Python and MATLAB for analysis, SolidWorks for CAD design, GitLab CI/CD and Jenkins for DevOps, and standard tools (Git, Docker, Linux, macOS, Windows).
Primary focus is transitioning diagnostic assays from prototype to production-scale manufacturing, including automated failure detection, supplier component qualification, and security hardening of the diagnostic platform.
Other companies in the same industry, closest in size